Jian Dong

Title: Jian Dong - Innovator in Pharmaceutical Chemistry

Introduction

Jian Dong is a prominent inventor based in Jiangyin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective inhibitors for cancer treatment. With a total of 2 patents, his work is paving the way for innovative therapeutic solutions.

Latest Patents

Jian Dong's latest patents include a selective CDK4/6 inhibitor and a preparation method for the same. This compound, represented by a specific formula, serves as a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6). It has potential applications in treating or preventing diseases that are modulated by CDK4/6. Another notable patent involves 2-arylamino pyridine, pyrimidine, or triazine derivatives. These derivatives are designed to target certain mutated forms of the epidermal growth factor receptor (EGFR), which are associated with various cancers. The patent outlines their preparation methods and potential uses in treating and preventing cancer.

Career Highlights

Jian Dong is currently associated with Wuxi Shuangliang Biotechnology Co., Ltd. His work at this company focuses on advancing pharmaceutical research and developing innovative treatments. His expertise in the field has led to significant advancements in cancer therapeutics.

Collaborations

Jian Dong collaborates with notable colleagues, including Jiaquan Wu and Shuai Zhang. Their combined efforts contribute to the innovative research and development initiatives at their company.

Conclusion

Jian Dong's contributions to pharmaceutical chemistry, particularly in cancer treatment, highlight his role as a leading inventor in the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.